Discover open access scientific publications

Search, annotate, share and cite publications

Publications by H Catt

Prm142 - Quantitative Benefit-Risk Modelling of Biosimilars: A Case Study of Infliximab in Crohn’s Disease.

Value in Health

Occupational Health

English

Related publications

Efficacy of Infliximab Biosimilars in Patients With Crohn's Disease

English

Comparison of Scheduled and Episodic Treatment Strategies of Infliximab in Crohn’s Disease

Gastroenterology

Gastroenterology

English

Exclusive Enteral Nutrition Versus Infliximab in Inducing Therapy of Pediatric Crohn’s Disease

Gastroenterology Research and Practice

Gastroenterology

English

Fulminant Legionellosis in Two Patients Treated With Infliximab for Crohn’s Disease: Case Series and Literature Review

Canadian Journal of Gastroenterology

English

Subtherapeutic Concentrations of Infliximab and Adalimumab Are Associated With Increased Disease Activity in Crohn’s Disease

Therapeutic Advances in Gastroenterology

Gastroenterology

English

Metastatic Hepatocellular Carcinoma in a Patient With Crohn’s Disease Treated With Azathioprine and Infliximab: A Case Report and Literature Review

Case Reports in Gastrointestinal Medicine

English

Pgi9 - Systematic Review and Meta-Analysis of the Efficacy of Infliximab Biosimilars in Inflammatory Bowel Disease Patients

Value in Health

Occupational Health

English

Cost-Minimization Analysis of Infliximab Versus Adalimumab in the Treatment of Crohn’s Disease and Ulcerative Colitis

Value in Health

Occupational Health

English

Infliximab Versus Adalimumab in Patients With Biologic-Naïve Crohn’s Disease: Is the Difference Real?

Digestive Diseases and Sciences

Gastroenterology

English